2011 RD 
2012 ME 
2013 MH 
2014 OPTIC PIT 
2015 CSCR 
2016 FLOATERS 
2017 ENDOPHTHALMITIS 
Poster Gavin Tan Introduction: Choroidal neovascularization (CNV) is rare but important cause of visual impairment in children. It is often idiopathic or secondary to inflammation, optic nerve head abnormalities or retinal dystrophies. There is a lack of clinical trials assessing the treatment of CNV in children. Methods: A 11-year-old boy with no past medical or ocular history presented with 3 months duration of reduced vision in his...
Read MoreBevacizumab for Subfoveal Choroidal Neovascularization in a Child
Posted by Gavin S. Tan, Ian Yeo and Adrian H. Koh on Oct 10, 2013 in Bevacizumab Avastin, Neovascularization / angiogenesis, Pediatry
Intravitreal Triamcinolone Versus Bevacizumab for Treatment of Subretinal Fluid in Diabetic Retinopathy
Posted by V. Levent Karabas, Berna Ozkan, Ruken Osmanoglu, Özgul Altintas and Nursen Yuksel on Oct 10, 2013 in Bevacizumab Avastin, Diabetes mellitus, Triamcinolone Acetonide and Steroids
Poster V. Levent Karabas Purpose: To evaluate the efficacy of intravitreal triamcinolone acetonite (IVT) injection versus intravitreal bevacizumab (IVB) injection in the management of subretinal fluid in patients with diabetic retinopathy. Methods: Forty-seven patient affected by diabetic macular edema with subretinal fluid were included. Patients were assigned randomly to two groups. IVT group, patients who received 4mg/0.1ml...
Read MoreRetinal Vessel Response to Intravitreal Bevacizumab in Diabetic Eyes
Posted by Osman Cekic, Mustafa M. Kurt and Ferhat Evliyaoglu on Oct 7, 2013 in Bevacizumab Avastin, Retinal vessels
Poster 2 Osman Cekic To measure retinal vessel diameters following intravitreal bevacizumab injection in eyes with diabetic macular oedema.
Read MoreMorphological Changes in Spectral Domain Optical Coherence Tomography Guided Bevacizumab Injections in Wet AMD, 12-months Results
Posted by Janusz Michalewski, Zofia Michalewska and Jerzy Nawrocki on Oct 4, 2013 in Bevacizumab Avastin, Exsudative ARMD, OCTs
Advantage: This paper aims to describe retinal changes during Spectral Domain Optical Coherence Tomography (SD-OCT) guided Bevacizumab treatment for neovascular age- related macular degeneration (AMD). Material and Methods: 47 eyes of 45 patients with wet AMD treated on demand with Bevacizumab. We used 3-dimensional SD-OCT to measure photoreceptor defects and subretinal fibrosis. The main efficacy endpoints were the SD-OCT measurements...
Read MoreThe Appropriate Timing of Pars Plana Vitrectomy After Pretreatment with Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy
Posted by Nabil Taresh, Basma Al-Refaei and Amin A. Okbah on Oct 4, 2013 in Bevacizumab Avastin, Proliferative diabetic retinopathy, Vitrectomy
Purpose: The purpose of this study was to determine the appropriate timing of pars plana vitrectomy after pretreatment with intravitreal bevacizumab (IVB) for proliferative diabetic retinopathy using histopathological examination of epiretinal membrane biopsies. Material & Methods: This prospective study was conducted in Maghrabi Eye Hospital & Kuwait University Hospital, Sana, between January 2009 – May 2010. Forty...
Read MoreEfficacy and Safety of Intravitreal Bevacizumab Monotherapy for Threshold Retinopathy of Prematurity
Posted by Sivakami A Pai, Afra M Lootah, Mohammed Atif, Manal O Taryam, Muhammad Fazal, Budoor A AlAmimi, Mohamed Kannas, Moza A Dekhain, Alaa Eldemerdash, Mahmoud S Elhalik, Laila M Almuhiri, Mahmoud G Ahmed and Anwar H Khan on Oct 4, 2013 in Bevacizumab Avastin, Retinopathy of prematurity
The introduction of Intraocular Anti-VEGFs agents have significantly improved the management of a wide variety of neovscular ocular diseases including retinopathy of prematurity (ROP). In our hands, monotherapy treatment with intravitreal bevacizumab (IVB) is a favourable treatment modality in management of threshold ROP. In eyes with iris rubeosis, rigid pupils and vitreous haze where it is difficult to visualize the fundus and perform...
Read MoreMeeting
